Published in Thromb Haemost on April 09, 2015
Prophylaxis Versus On-demand Therapy Through Economic Report (POTTER) | NCT01159587
Adherence to treatment regimen and bleeding rates in a prospective cohort of youth and young adults on low-dose daily prophylaxis for severe hemophilia A. BMC Hematol (2016) 0.75
Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations? Thromb J (2016) 0.75
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med (2007) 6.76
Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med (2013) 2.99
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica (2008) 2.46
Systematic review of the role of FVIII concentrates in inhibitor development in previously untreated patients with severe hemophilia a: a 2013 update. Semin Thromb Hemost (2013) 2.19
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke (2002) 1.64
Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study. Br J Haematol (2005) 1.63
Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. Blood (2013) 1.51
Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial. Thromb Haemost (2007) 1.41
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation (2008) 1.26
How we choose factor VIII to treat hemophilia. Blood (2012) 1.17
Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines. Acta Haematol (2009) 1.16
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation (2003) 1.13
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. Blood (2007) 1.13
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis. Thromb Haemost (2015) 1.06
Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost (2010) 0.98
Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost (2010) 0.97
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. Haematologica (2007) 0.97
Haemophilia A: molecular insights. Clin Chem Lab Med (2007) 0.96
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. Am J Hematol (2010) 0.95
Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol (2003) 0.95
Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues. Thromb Haemost (2009) 0.94
A comparative study of fine needle aspiration and fine needle non-aspiration biopsy on suspected thyroid nodules. Endocr Pathol (2009) 0.94
Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost (2010) 0.93
Safety of dental implant surgery in patients undergoing anticoagulation therapy: a prospective case-control study. Clin Oral Implants Res (2010) 0.93
A long-term study of young patients with essential thrombocythemia treated with anagrelide. Haematologica (2004) 0.91
The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica (2008) 0.91
Pain and distress from bone marrow aspirations and lumbar punctures. Ann Pharmacother (2003) 0.91
Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis (2006) 0.91
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database Syst Rev (2015) 0.90
Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol (2004) 0.90
The infectious burden in atherothrombosis. Semin Thromb Hemost (2012) 0.90
Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors. Curr Med Res Opin (2006) 0.90
Homocysteine and arterial thrombosis: Challenge and opportunity. Thromb Haemost (2010) 0.89
The laboratory approach to inherited and acquired coagulation factor deficiencies. Clin Lab Med (2009) 0.89
Acquired haemophilia a in the elderly: case reports. Curr Gerontol Geriatr Res (2010) 0.89
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. Clin Chem (2005) 0.89
Denaturing HPLC procedure for factor IX gene scanning. Clin Chem (2003) 0.88
Secondary prophylaxis in adolescent and adult haemophiliacs. Blood Transfus (2008) 0.87
Hemophilia and cancer: a new challenge for hemophilia centers. Cancer Treat Rev (2009) 0.87
Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs. Thromb Haemost (2006) 0.87
Anaphylaxis in patients with congenital bleeding disorders and inhibitors. Blood Coagul Fibrinolysis (2009) 0.87
Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost (2012) 0.86
Incidence of catheter-related infections within 30 days from insertion of Hickman-Broviac catheters. Pediatr Blood Cancer (2007) 0.86
Dopamine versus dobutamine in very low birthweight infants: endocrine effects. Arch Dis Child Fetal Neonatal Ed (2007) 0.86
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation. Ann Hematol (2009) 0.86
Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost (2011) 0.85
Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica (2006) 0.85
Haemophilia B: from molecular diagnosis to gene therapy. Clin Chem Lab Med (2003) 0.85
The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study. Haematologica (2006) 0.84
Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities. Semin Thromb Hemost (2013) 0.84
Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia. AIDS (2007) 0.84
No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease. Thromb Res (2002) 0.84
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med (2011) 0.84
Cost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia A. Clinicoecon Outcomes Res (2011) 0.84
Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost (2006) 0.83
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Haematologica (2006) 0.82
Cerebrovascular disease and varicella in children. Brain Dev (2006) 0.82
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. Am J Hematol (2010) 0.82
Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis (2010) 0.82
Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost (2013) 0.81
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. Pediatr Blood Cancer (2009) 0.81
Mouse embryonic stem cells that survive γ-rays exposure maintain pluripotent differentiation potential and genome stability. J Cell Physiol (2012) 0.81
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81
FEIBA versus NovoSeven in hemophilia patients with inhibitors. Semin Thromb Hemost (2013) 0.81
Patient preference for needleless factor VIII reconstitution device: the Italian experience. Int J Gen Med (2010) 0.81
A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? Blood Transfus (2011) 0.80
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients. Am J Hematol (2014) 0.80
Arthropathy in patients with moderate hemophilia a: a systematic review of the literature. Semin Thromb Hemost (2013) 0.80
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1). Thromb Res (2011) 0.80
Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies. Semin Thromb Hemost (2011) 0.79
Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia. Blood Transfus (2012) 0.79
Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost (2003) 0.79
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin. Eur J Haematol (2010) 0.79
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. Haemophilia (2014) 0.79
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. Clin Appl Thromb Hemost (2007) 0.78
Flow-mediated arterial dilation in primary antiphospholipid syndrome. Angiology (2008) 0.78
Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single center. Clin Appl Thromb Hemost (2009) 0.78
Predisposing factors in patients with early-onset cerebral vein thrombosis. Thromb Res (2004) 0.78
Non-O blood group as a risk factor for cerebral vein thrombosis. Thromb Haemost (2013) 0.78
Small FVIII gene rearrangements in 18 hemophilia A patients: five novel mutations. Am J Hematol (2005) 0.78
A single institution observational study of early mechanical complications in central venous catheters (valved and open-ended) in children with cancer. Pediatr Surg Int (2004) 0.78
Multilevel en bloc spondylectomy for tumors of the thoracic and lumbar spine is challenging but rewarding. Clin Orthop Relat Res (2015) 0.77
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. Thromb Res (2011) 0.77
Issues in pediatric haemophilia care. Ital J Pediatr (2013) 0.77
Thrombophilia and pregnancy complications. Thromb Haemost (2004) 0.77
Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus. Thromb Haemost (2006) 0.77